Volume 8, Issue 2 (2022)                   Pharm Biomed Res 2022, 8(2): 91-94 | Back to browse issues page

XML Print

1- Department of Basic Sciences, Faculty of Medical Sciences, Behbahan University of Medical Sciences, Behbahan, Iran.
2- Department of Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract:   (2355 Views)
The coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to the high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and belongs to the large Coronaviridae family [1]. 
Full-Text [PDF 401 kb]   (1234 Downloads) |   |   Full-Text (HTML)  (1402 Views)  
Type of Study: Short Communication | Subject: Pharmacology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.